At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,020 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Baseline Features and CHA2DS2 VASc /HAS BLED Scores of Jordanian Patients With Atrial Fibrillation and the One Year Outcome
In Brief
An observational study for Atrial Fibrillation. Completed, enrolled 2,020 participants across 8 sites.
Detailed Summary
The Jordanian AF study, the first of its kind in Jordan, will evaluate patients with AF in an in-patient and out-patient settings. The morbidity and mortality associated with AF has not been studied in this region especially with the relation to the HAD BLED and CHADS VAC score.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesJordan
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedApr 2019
Enrollment StartMay 2019
Primary CompletionNov 2021
TodayJul 2026
First PostedApr 17, 2019
Enrollment StartMay 25, 2019
Primary CompletionNov 25, 2021
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 7.2 years ago